Clear Clinical Research Limited 08741372 false 2023-11-01 2025-04-30 2025-04-30 The principal activity of the company is clinical research and medical writing. Digita Accounts Production Advanced 6.30.9574.0 true 08741372 2023-11-01 2025-04-30 08741372 2025-04-30 08741372 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 08741372 1 2025-04-30 08741372 bus:Micro-entities 2023-11-01 2025-04-30 08741372 bus:AuditExemptWithAccountantsReport 2023-11-01 2025-04-30 08741372 bus:FilletedAccounts 2023-11-01 2025-04-30 08741372 bus:SmallCompaniesRegimeForAccounts 2023-11-01 2025-04-30 08741372 bus:RegisteredOffice 2023-11-01 2025-04-30 08741372 bus:Director1 2023-11-01 2025-04-30 08741372 bus:PrivateLimitedCompanyLtd 2023-11-01 2025-04-30 08741372 bus:Agent1 2023-11-01 2025-04-30 08741372 countries:EnglandWales 2023-11-01 2025-04-30 08741372 1 2023-11-01 2025-04-30 08741372 1 2023-10-31 08741372 2022-11-01 2023-10-31 08741372 2023-10-31 08741372 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 08741372 1 2023-10-31 08741372 1 2022-11-01 2023-10-31 08741372 1 2022-10-31 iso4217:GBP xbrli:pure

Registration number: 08741372

Clear Clinical Research Limited

Unaudited Filleted Financial Statements

for the Period from 1 November 2023 to 30 April 2025

 

Clear Clinical Research Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Clear Clinical Research Limited

Company Information

Director

A. J. Thompson

Registered office

Westwood House
78 Loughborough Road
Quorn
Loughborough
LE12 8DX

Accountants

Robert Whowell & Partners LLP
Chartered AccountantsWestwood House
78 Loughborough Road
Quorn
Loughborough
Leicestershire
LE12 8DX

 

Clear Clinical Research Limited

(Registration number: 08741372)
Balance Sheet as at 30 April 2025

30 April
2025
£

31 October
2023
£

Fixed assets

-

-

Current assets

35,100

71,386

Prepayments and accrued income

215

160

Creditors: Amounts falling due within one year

(9,038)

(7,545)

Net current assets

26,277

64,001

Total assets less current liabilities

26,277

64,001

Accruals and deferred income

(1,920)

(1,400)

 

24,357

62,601

Capital and reserves

24,357

62,601

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Westwood House
78 Loughborough Road
Quorn
Loughborough
LE12 8DX

These financial statements were authorised for issue by the director on 24 October 2025.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1 (2023 - 1).

 

Clear Clinical Research Limited

(Registration number: 08741372)
Balance Sheet as at 30 April 2025

3

Related party transactions

Transactions with the director

2025

At 1 November 2023
£

Advances to director
£

Repayments by director
£

At 30 April 2025
£

Director's loan account

12,021

63,342

(77,859)

(2,496)

 

2023

At 1 November 2022
£

Advances to director
£

Repayments by director
£

At 31 October 2023
£

Director's loan account

17,519

47,500

(52,998)

12,021

 

The loan brought forward was repaid on 6 April 2024.

For the financial period ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 24 October 2025
 

.........................................
A. J. Thompson
Director